Načítá se...
IPX066: a new intermediate-and extended-release carbidopa–levodopa formulation
Carbidopa–levodopa (CD–LD) is the mainstay of treatment for Parkinson’s disease (PD), yet most patients with advanced PD develop motor fluctuations with time when treated with CD–LD. Development of longer-acting CD–LD formulations is a major goal for reducing motor fluctuations in advanced PD. IPX06...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3910659/ https://ncbi.nlm.nih.gov/pubmed/24501594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.13.4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|